Use this URL to cite or link to this record in EThOS: http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.626217
Title: An ultra scale-down study of recovery by centrifugation of human cells for therapy
Author: Delahaye, M. T.
Awarding Body: University College London (University of London)
Current Institution: University College London (University of London)
Date of Award: 2013
Availability of Full Text:
Access through EThOS:
Full text unavailable from EThOS. Please try the link below.
Access through Institution:
Abstract:
The future success of the cell therapy sector depends largely upon the ability to produce large numbers of high quality and efficacious cells. Within the production of living cells, the product and process become inseparable, thus, the selection and implementation of a large scale commercial production process becomes crucial to the success of the therapy. Traditional cell therapy lifecycles from the discovery phase through to patient administration utilise various unit operations, necessary for expansion, primary recovery, purification and final formulation. It is the induction of variation within cell populations caused whilst processed within these processes that can potentially render the product ineffective and unusable, creating major concern within the healthcare sector. This body of work casts focus upon the recovery of human cells intended for therapeutic use by centrifugation and sediment resuspension, a commonly adopted process which facilitates primary recovery, cell washing and purification processes, as well as the concentration of cells to a final administration specification. With the creation of ultra scale-down techniques coupled with a Design of Experiments approach, the impact of key unit associated parameters such as centrifugation spin time and intensity, along with the technique adopted for sediment resuspension has been characterised for three different human cell lines intended for therapy. A potential developmental roadmap has been created for the production and evaluation of cells for therapies. A range of cell quality attributes were evaluated forming the characterisation criteria, encompassing the analysis of structural integrity, surface marker profiling, cell death induction, cell proliferation capacity, a change in cell size and morphology, the induction of cell signalling in the form of cytokine release and crucially, the potency of the therapy. This facilitated an indepth view into the response of cells when processed, exemplifying the somewhat robust capacity of human cells. This work has aided the formation of a mechanistic hypothesis concerning cell damage as a consequence of the process. Traditional centrifugation protocols operate at the lower extremes of the design space investigated, so characterisation can inform as to the limits of manufacturing at large scale. Critical process effects affecting the recovery of viable cells included (i) the cell preparation with long hold times leading to greater loss during centrifugation and (ii) the method of cell pellet resuspension with the use of few passes at high velocities resulting in greater loss than many passes at low velocity. The mechanisms behind these and other process induced damage are explored.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.626217  DOI: Not available
Share: